Efficacy and Safety of Balugrastim Compared With Pegfilgrastim in Patients With Breast Cancer Receiving Chemotherapy

2006 Update of Recommendations for the Use of White Blood Cell Growth Factors: An Evidence-Based Clinical Practice Guideline

Thomas J. Smith, James Khatcheressian, Gary H. Lyman et al. · Journal of Clinical Oncology · 2006 · 1.6K citations · Full text

Medicine, Hematology, Oncology +17

Reduction by Granulocyte Colony-Stimulating Factor of Fever and Neutropenia Induced by Chemotherapy in Patients with Small-Cell Lung Cancer

Jeffrey Crawford, Howard Ozer, Ronald G. Stoller et al. · New England Journal of Medicine · 1991 · 1.4K citations

Life Sciences, Immunology, Oncology +16

2000 Update of Recommendations for the Use of Hematopoietic Colony-Stimulating Factors: Evidence-Based, Clinical Practice Guidelines

Howard Ozer, Jamés O. Armitage, Charles L. Bennett et al. · Journal of Clinical Oncology · 2000 · 1K citations

Medicine, Hematology, Oncology +8

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

V. Trillet-Lenoir, J. Green, C. Manegold et al. · European Journal of Cancer · 1993 · 545 citations

Medicine, Immunology, Oncology +15

Blinded, Randomized, Multicenter Study to Evaluate Single Administration Pegfilgrastim Once per Cycle Versus Daily Filgrastim as an Adjunct to Chemotherapy in Patients With High-Risk Stage II or Stage III/IV Breast Cancer

Frankie A. Holmes, Joyce O’Shaughnessy, S. Vukelja et al. · Journal of Clinical Oncology · 2002 · 517 citations

Medicine, Oncology, Pharmacology +17